Deutsche Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-572
| Closed | -$30K | – | 4050 |
|
|
2022
Q2 | $30K | Hold |
572
| – | – | ﹤0.01% | 3868 |
|
|
2022
Q1 | $30K | Hold |
572
| – | – | ﹤0.01% | 3975 |
|
|
2021
Q4 | $34K | Buy |
572
+397
| +227% | +$19.7K | ﹤0.01% | 4054 |
|
|
2021
Q3 | $8K | Sell |
175
-525
| -75% | -$23.3K | ﹤0.01% | 4305 |
|
|
2021
Q2 | $27K | Sell |
700
-100
| -13% | -$3.89K | ﹤0.01% | 4393 |
|
|
2021
Q1 | $29K | Buy |
+800
| New | +$28.4K | ﹤0.01% | 4345 |
|
|
2020
Q2 | – | Sell |
-116
| Closed | -$4K | – | 4407 |
|
|
2020
Q1 | $4K | Buy |
116
+31
| +36% | +$1.06K | ﹤0.01% | 4173 |
|
|
2019
Q4 | $3K | Hold |
85
| – | – | ﹤0.01% | 4773 |
|
|
2019
Q3 | $2K | Sell |
85
-949
| -92% | -$34.5K | ﹤0.01% | 4777 |
|
|
2019
Q2 | $42K | Sell |
1,034
-601
| -37% | -$23.9K | ﹤0.01% | 4579 |
|
|
2019
Q1 | $65K | Buy |
1,635
+212
| +15% | +$8.49K | ﹤0.01% | 4474 |
|
|
2018
Q4 | $58K | Sell |
1,423
-779
| -35% | -$32.3K | ﹤0.01% | 4428 |
|
|
2018
Q3 | $92K | Sell |
2,202
-6,087
| -73% | -$234K | ﹤0.01% | 4525 |
|
|
2018
Q2 | $286K | Sell |
8,289
-5,012
| -38% | -$171K | ﹤0.01% | 4130 |
|
|
2018
Q1 | $446K | Buy |
13,301
+5,287
| +66% | +$182K | ﹤0.01% | 3777 |
|
|
2017
Q4 | $274K | Buy |
8,014
+502
| +7% | +$17.1K | ﹤0.01% | 3882 |
|
|
2017
Q3 | $254K | Buy |
7,512
+5,431
| +261% | +$175K | ﹤0.01% | 3761 |
|
|
2017
Q2 | $66K | Sell |
2,081
-31,811
| -94% | -$1M | ﹤0.01% | 4315 |
|
|
2017
Q1 | $1.1M | Buy |
33,892
+29,410
| +656% | +$927K | ﹤0.01% | 2593 |
|
|
2016
Q4 | $137K | Sell |
4,482
-2,494
| -36% | -$76.1K | ﹤0.01% | 3904 |
|
|
2016
Q3 | $223K | Sell |
6,976
-9,226
| -57% | -$308K | ﹤0.01% | 3594 |
|
|
2016
Q2 | $540K | Sell |
16,202
-43,355
| -73% | -$1.38M | ﹤0.01% | 3246 |
|
|
2016
Q1 | $1.67M | Buy |
59,557
+48,770
| +452% | +$1.39M | ﹤0.01% | 2487 |
|
|
2015
Q4 | $329K | Buy |
10,787
+4,545
| +73% | +$143K | ﹤0.01% | 3470 |
|
|
2015
Q3 | $184K | Sell |
6,242
-2,354
| -27% | -$75.5K | ﹤0.01% | 3832 |
|
|
2015
Q2 | $273K | Buy |
+8,596
| New | +$280K | ﹤0.01% | 3729 |
|
|
2015
Q1 | – | Sell |
-28,049
| Closed | -$828K | – | 5727 |
|
|
2014
Q4 | $828K | Sell |
28,049
-3,231
| -10% | -$92.6K | ﹤0.01% | 3336 |
|
|
2014
Q3 | $877K | Sell |
31,280
-5,791
| -16% | -$163K | ﹤0.01% | 3125 |
|
|
2014
Q2 | $1.04M | Buy |
37,071
+28,447
| +330% | +$811K | ﹤0.01% | 2909 |
|
|
2014
Q1 | $13K | Sell |
8,624
-12,193
| -59% | -$364K | ﹤0.01% | 4958 |
|
|
2013
Q4 | $16K | Buy |
20,817
+583
| +3% | +$17K | ﹤0.01% | 4796 |
|
|
2013
Q3 | $9K | Sell |
20,234
-261,621
| -93% | -$7.12M | ﹤0.01% | 5066 |
|
|
2013
Q2 | $4K | Buy |
+281,855
| New | +$7.79M | ﹤0.01% | 5069 |
|
Other funds holding PFE
VCM
VPM
Deutsche Bank's PFE Position: Q1 2026 in Review
Deutsche Bank increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $14.1M and bringing the position to 31,428,987 shares worth $883M. The position accounts for 0.29% of the portfolio, ranked #68.
Deutsche Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.22B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Deutsche Bank held 31,428,987 shares of Pfizer worth $883M as of Q1 2026.
- Deutsche Bank bought 530,139 Pfizer shares in Q1 2026, an estimated $14.1M.
- Pfizer made up 0.29% of Deutsche Bank's portfolio in Q1 2026, its #68 holding.
- Deutsche Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Pfizer position peaked at $2.22B in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.